Ottavia Prunas

447 total citations
9 papers, 208 citations indexed

About

Ottavia Prunas is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Ottavia Prunas has authored 9 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Health and 3 papers in Epidemiology. Recurrent topics in Ottavia Prunas's work include Vaccine Coverage and Hesitancy (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Ottavia Prunas is often cited by papers focused on Vaccine Coverage and Hesitancy (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Pneumonia and Respiratory Infections (3 papers). Ottavia Prunas collaborates with scholars based in United States, Switzerland and Israel. Ottavia Prunas's co-authors include Daniel M. Weinberger, Joshua L. Warren, Virginia E. Pitzer, Sivan Gazit, Tal Patalon, Forrest W. Crawford, Sara L. Nason, James E. Saiers, Nicole C. Deziel and Duccio Medini and has published in prestigious journals such as Science, Environmental Science & Technology and Clinical Infectious Diseases.

In The Last Decade

Ottavia Prunas

9 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ottavia Prunas United States 4 165 88 70 28 13 9 208
Kimberly Groover United States 3 148 0.9× 88 1.0× 57 0.8× 18 0.6× 9 0.7× 3 184
Frederik Plesner Lyngse Denmark 4 150 0.9× 44 0.5× 66 0.9× 29 1.0× 6 0.5× 5 185
Olivia Chény France 5 123 0.7× 28 0.3× 95 1.4× 17 0.6× 7 0.5× 12 200
Aidan Irwin-Singer United Kingdom 7 239 1.4× 92 1.0× 92 1.3× 14 0.5× 8 0.6× 9 296
Mie Agermose Gram Denmark 8 236 1.4× 113 1.3× 61 0.9× 34 1.2× 12 0.9× 15 300
Chayada Piantham Japan 5 179 1.1× 21 0.2× 102 1.5× 21 0.8× 10 0.8× 7 233
Tiffany Charmet France 5 124 0.8× 34 0.4× 102 1.5× 18 0.6× 7 0.5× 16 208
Valeria Filippi Italy 5 177 1.1× 38 0.4× 20 0.3× 41 1.5× 15 1.2× 7 248
Murilo Dorión Brazil 3 226 1.4× 119 1.4× 61 0.9× 20 0.7× 15 1.2× 3 261
Regiane Cardoso de Paula Brazil 3 224 1.4× 116 1.3× 56 0.8× 17 0.6× 15 1.2× 9 257

Countries citing papers authored by Ottavia Prunas

Since Specialization
Citations

This map shows the geographic impact of Ottavia Prunas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ottavia Prunas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ottavia Prunas more than expected).

Fields of papers citing papers by Ottavia Prunas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ottavia Prunas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ottavia Prunas. The network helps show where Ottavia Prunas may publish in the future.

Co-authorship network of co-authors of Ottavia Prunas

This figure shows the co-authorship network connecting the top 25 collaborators of Ottavia Prunas. A scholar is included among the top collaborators of Ottavia Prunas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ottavia Prunas. Ottavia Prunas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Prunas, Ottavia, Ernest O. Asare, Daniel M. Weinberger, et al.. (2025). Global estimates of rotavirus vaccine efficacy and effectiveness: a rapid review and meta-regression analysis. EClinicalMedicine. 81. 103122–103122. 3 indexed citations
2.
Prunas, Ottavia, Kayoko Shioda, Cristiana M. Toscano, et al.. (2024). Estimated Population-Level Impact of Pneumococcal Conjugate Vaccines Against All-Cause Pneumonia Mortality Among Unvaccinated in 5 Latin American Countries. The Journal of Infectious Diseases. 230(4). e768–e776. 1 indexed citations
3.
Prunas, Ottavia, et al.. (2024). Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents. npj Vaccines. 9(1). 239–239. 1 indexed citations
4.
Prunas, Ottavia, Joukje E. Willemsen, Louis Bont, et al.. (2023). Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines. Epidemiology. 35(1). 103–112. 1 indexed citations
5.
Nason, Sara L., et al.. (2023). Investigation of Sources of Fluorinated Compounds in Private Water Supplies in an Oil and Gas-Producing Region of Northern West Virginia. Environmental Science & Technology. 57(45). 17452–17464. 14 indexed citations
6.
Prunas, Ottavia, Daniel M. Weinberger, Virginia E. Pitzer, Sivan Gazit, & Tal Patalon. (2022). Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel. Clinical Infectious Diseases. 76(1). 113–118. 10 indexed citations
7.
Prunas, Ottavia, Joshua L. Warren, Forrest W. Crawford, et al.. (2022). Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science. 375(6585). 1151–1154. 85 indexed citations
8.
Prunas, Ottavia, et al.. (2021). Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. American Journal of Epidemiology. 191(4). 724–734. 3 indexed citations
9.
Patalon, Tal, Sivan Gazit, Virginia E. Pitzer, et al.. (2021). Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine. JAMA Internal Medicine. 182(2). 179–179. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026